137 related articles for article (PubMed ID: 4268202)
1. Monitoring antifibrinolytic therapy in subarachnoid hemorrhage.
Smith RR; Upchurch JJ
J Neurosurg; 1973 Mar; 38(3):339-44. PubMed ID: 4268202
[No Abstract] [Full Text] [Related]
2. Streptokinase clot lysis time in patients with ruptured intracranial aneurysms.
Geronemus R; Herz DA; Shulman K
J Neurosurg; 1974 Apr; 40(4):499-503. PubMed ID: 4814382
[No Abstract] [Full Text] [Related]
3. Fibrinolytic activity in blood and cerebrospinal fluid in subarachnoid hemorrhage from ruptured intracranial saccular aneurysm before and during EACA treatment.
Filizzolo F; D'angelo V; Collice M; Ferrara M; Donati MB; Porta M
Eur Neurol; 1978; 17(1):43-7. PubMed ID: 624294
[TBL] [Abstract][Full Text] [Related]
4. Letter: Epsilon-aminocaproic acid.
Shaw MD; Miller JD
Lancet; 1974 Nov; 2(7891):1264. PubMed ID: 4139496
[No Abstract] [Full Text] [Related]
5. Antifibrinolytic activity during administration of epsilon-aminocaproic acid.
Nibbelink DW
Stroke; 1971; 2(6):555-8. PubMed ID: 5164583
[No Abstract] [Full Text] [Related]
6. Antifibrinolytic therapy for intracranial aneurysms.
Mullan S; Dawley J
J Neurosurg; 1968 Jan; 28(1):21-3. PubMed ID: 5639737
[No Abstract] [Full Text] [Related]
7. Biochemical changes after spontaneous subarachnoid haemorrhage. 3. Coagulation and lysis with special reference to recurrent haemorrhage.
Uttley AH; Buckell M
J Neurol Neurosurg Psychiatry; 1968 Dec; 31(6):621-7. PubMed ID: 5709849
[No Abstract] [Full Text] [Related]
8. Epsilon-aminocaproic acid and recurrent subarachnoid hemorrhage: a clinical trial.
Shucart WA; Hussain SK; Cooper PR
J Neurosurg; 1980 Jul; 53(1):28-31. PubMed ID: 7411206
[TBL] [Abstract][Full Text] [Related]
9. Antifibrinolytics in the treatment of subarachnoid hemorrhages due to ruptured aneurysms.
Schisano G
J Neurosurg Sci; 1975; 19(1-2):79-80. PubMed ID: 1082929
[No Abstract] [Full Text] [Related]
10. [Hemostatic processes in aneurysmal hemorrhages].
Hindersin P; Heidrich R
Psychiatr Neurol Med Psychol (Leipz); 1977 Mar; 29(3):129-44. PubMed ID: 877166
[TBL] [Abstract][Full Text] [Related]
11. The use of antifibrinolytic substances in ruptured intracranial aneurysms.
Norlén G; Thulin CA
Neurochirurgia (Stuttg); 1969 May; 12(3):100-2. PubMed ID: 5790480
[No Abstract] [Full Text] [Related]
12. Antifibrinolytic therapy in subarachnoid hemorrhage caused by ruptured intracranial aneurysm.
Ramirez-Lassepas M
Neurology; 1981 Mar; 31(3):316-22. PubMed ID: 7010208
[TBL] [Abstract][Full Text] [Related]
13. [Current status of intrathecal antifibrinolytic therapy with p-aminomethylbenzoic acid (PAMBA) in subarachnoid hemorrhages].
Hindersin P; Endler S; Heidrich R; Lehmann W; Dietrich J
Psychiatr Neurol Med Psychol (Leipz); 1985 Dec; 37(12):686-9. PubMed ID: 3879362
[TBL] [Abstract][Full Text] [Related]
14. Antifibrinolytic therapy in ruptured intracranial aneurysm through repeated monitoring of fibrinolytic activity of blood.
Watanabe H; Ito M; Chigasaki H; Ishii S
Neurol Med Chir (Tokyo); 1976; 16(PT1):91-6. PubMed ID: 66644
[No Abstract] [Full Text] [Related]
15. Antifibrinolytic therapy in patients with aneurysmal subarachnoid hemorrhage. A report of the cooperative aneurysm study.
Adams HP; Nibbelink DW; Torner JC; Sahs AL
Arch Neurol; 1981 Jan; 38(1):25-9. PubMed ID: 7458720
[TBL] [Abstract][Full Text] [Related]
16. The fibrinolytic activity of cerebrospinal fluid after subarachnoid hemorrhage.
Steinmetz H; Grote E
Neurol Res; 1983; 5(4):59-65. PubMed ID: 6149487
[TBL] [Abstract][Full Text] [Related]
17. [Effectiveness of antifibrinolytic, edema-preventing and hypotensive agents in the prevention of recurrent bleeding from intracranial aneurysms].
Bromowicz J; Bryniarska D; Koniar-Danilewicz H; Danilewicz B
Neurol Neurochir Pol; 1979; 13(6):647-51. PubMed ID: 514441
[TBL] [Abstract][Full Text] [Related]
18. Current status of antifibrinolytic therapy for treatment of patients with aneurysmal subarachnoid hemorrhage.
Adams HP
Stroke; 1982; 13(2):256-9. PubMed ID: 7039006
[No Abstract] [Full Text] [Related]
19. Fibrinolysis and subarachnoid haemorrhage. Inhibitory effect of tranexamic acid. A clinical study.
Tovi D; Nilsson IM; Thulin CA
Acta Neurol Scand; 1972; 48(4):393-402. PubMed ID: 5072650
[No Abstract] [Full Text] [Related]
20. Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: effect of tranexamic acid (AMCA).
Fodstad H; Nilsson IM
Acta Neurochir (Wien); 1981; 56(1-2):25-38. PubMed ID: 7195642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
